Max Brosa
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Asthma and respiratory diseases, Hepatitis C virus research, Lipoproteins and Cardiovascular Health
Most-Cited Works
- → The association between asthma control, health care costs, and quality of life in France and Spain(2013)124 cited
- → Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C(2005)109 cited
- → Estimate of the total costs of allergic rhinitis in specialized care based on real‐world data: the FERIN Study(2016)93 cited
- → Costes directos de la diabetes mellitus y de sus complicaciones en España (Estudio SECCAID: Spain estimated cost Ciberdem-Cabimer in Diabetes)(2013)91 cited
- → The health care burden and societal impact of acute otitis media in seven European countries: Results of an Internet survey(2010)85 cited
- → Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B(2009)81 cited
- → PREDyCES study: The cost of hospital malnutrition in Spain(2015)66 cited
- → Principios, métodos y aplicaciones del análisis del impacto presupuestario en el sector sanitario(2005)63 cited
- → Treatment patterns, use of resources, and costs of advanced non-small-cell lung cancer patients in Spain: results from a Delphi panel(2011)55 cited
- → Cost-Effectiveness of Sacral Neuromodulation Compared to Botulinum Neurotoxin A or Continued Medical Management in Refractory Overactive Bladder(2011)54 cited